CONTEXT AND OBJECTIVE: Many uncertainties concerning risk factors and evolution of cognitive disorders remain. We describe the methods and preliminary results from the investigation of the cognitive function in the Longitudinal Study on Adult Health (ELSA-Brasil). DESIGN AND SETTING: Multicenter cohort study on public employees at six public teaching and research institutions.
Cruz, Fiocruz). This study is investigating the incidence and evolution of chronic diseases, especially cardiovascular diseases and diabetes, among adults. 1 In this article, we present the methodology of the cognitive function investigation and the sociodemographic characteristics of the study population.
The increases in life expectancy and the rapid aging process observed in developing countries are occurring in a context of social inequalities and structural difficulties, since these countries are institutionally unprepared to meet the great demands associated with ageing. Even though aging is a victory for humanity, it increases the risk of chronic diseases and functional dependency. Over the next few years, an alarming number of Brazilians will reach an age at which the incidence of dementia is high.
Estimates from population studies in Latin America and Brazil have shown that the prevalence of dementia increases from less than 10% up to the age of 75 years to more than 40% among individuals aged 85 years or over, which is precisely the age stratum that is expanding most rapidly among elderly Brazilians. 2 Dementia is a serious syndrome that compromises the memory and at least one more cognitive function, thereby leading to declining social and occupational capacities. Moreover, cognitive impairment without dementia has emerged as an important clinical entity, and its prevalence is twice as high as the prevalence of all forms of dementia combined. In addition, it has high rates of progression towards dementia, estimated to be 10% to 15% a year, in relation to the rates among individuals without cognitive deficit (1% to 2% a year). 3 The question that therefore arises is whether memory loss without dementia is a benign process, with slow progression; or whether it should be understood as the initial phase of more significant cognitive losses, which could lead to dementia. A five-year follow-up study found that people with cognitive impairment, but without dementia presented higher risks of diagnoses of dementia (47% versus 15%), or dying (49% versus 30%), or being admitted to long-term institutional care (29% versus 14%), in comparison with those without cognitive impairment. 4 There is evidence that the decline in cognitive function begins during adult ages, even before the age of 50 years, and that its development is continuous over a 20 to 30-year period. 4 However, not all components of cognitive function are equally affected by age: environmental, social and behavioral factors are also determinants in this process. Nonetheless, there are still many doubts regarding the role of risk factors, and the quality and extent of these changes. There are few cohort studies on cognitive disorders in Latin America; most of them are concentrated on the elderly population. 2, 5, 6 Developed countries have already a significant number of community-based cohort studies on adults in the age range of 45-64 years, i.e. "middle-age", although most studies are still concentrated on the elderly. [7] [8] [9] Many studies have suggested that cardiovascular risk factors contribute towards development of dementia, and cohort studies have demonstrated a consistent association between midlife health situations and the incidence of late-life dementia. Midlife hypertension presented a more significant association with the incidence of dementia than does late-life hypertension. [10] [11] [12] Treatment for hypertension has been correlated with lower incidence of dementia, but the results are still difficult to interpret. 13 Common mental disorders, especially anxiety and depression, have great interaction with cognitive function. They can be risk factors for cognitive deficits, confounding factors in performing cognitive tests, or even part of the initial signs of dementia (protopathic bias). 26 Despite extensive research, many uncertainties concerning risk factors for dementia remain. These uncertainties include lack of comparability and standardization of the outcomes (performance in tests; dementia or Alzheimer's disease); study design (cross-sectional, cohort or clinical trial); diversity of the samples included in the studies (Japanese men, nuns, white women and British workers); exposure (throughout life, midlife or late life); and diagnostic instruments (cognitive tests, neurological examinations or brain imaging). There have also been some difficulties in including the diagnoses of certain types of dementia.
In 2010, after reviewing the literature on risk factors for Alzheimer's disease, a panel of specialists took the view that strong evidence only exists regarding genetic factors (variation of the Apo E gene), and that the evidence was weak in relation to the effects of midlife hypertension, diabetes, depression, current smoking, low-fat diets, folic acid intake, moderate alcohol consumption, low social support and never having been married.
They also concluded that there was no consistent association between the effects of obesity, metabolic syndrome and blood pressure and use of anti-hypertensive medications, non-steroidal anti-inflammatory drugs or gonadal steroids. They indicated that the following were the main deficiencies of epidemiological studies: difficulty in distinguishing between association and causality; lack of standardization in defining cases; and complexity in establishing whether associated variables, such as depression and weight loss, are risk factors or, in reality, are early signs of Alzheimer's disease.
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OBJECTIVES
The aim here was to present the methodology used to investigate cognitive function and the sociodemographic characteristics of the study population of ELSA-Brasil.
METHODS
The baseline data collection was completed in 2010, and all participants were interviewed and examined in order to obtain a comprehensive range of psychosocial, environmental and clinical characteristics ( Table 1) . Since then, telephone followup interviews have been taking place annually and the first three-year interval follow-up examinations were conducted in September 2012. The object of the cognitive investigation was to identify changes in cognitive tests, which may be of transitory nature and may or may not be reversible, and to identify irreversible final outcomes such as occurrences of all types of dementia. Other than the abovementioned strategies, it was planned that occurrences of outcomes would be investigated by correlating data with secondary databases such as mortality and hospitalization rates. 1 Every public employee at the institutions involved, between the ages of 35 and 74 years, was considered eligible. Individuals who intended to leave the institution, those who presented severe cognitive deficit, pregnant women, those who were retired and those who did not live in one of the six metropolitan regions were excluded. The sample size was calculated based on the incidence of type 2 diabetes and myocardial infarction and resulted in 6,400 participants. The cohort was composed by volunteers and a random sample was derived from it. ELSA has a dual system of recruitment, in which part of the sample consists of volunteers and part is derived from an actively recruited random sample of eligible individuals drawn from lists from the institutions. 1 The total sample would be used to examine the association of risk factors with cognitive decline and dementia, while the random sample would make it possible to estimate the frequency and distribution of cognitive deficits. were unable to read. 29 The verbal fluency tests consisted of ask- Total blood cell count, plasma glucose, oral glucose tolerance test, HbA1c, creatinine, total, HDL and LDL-cholesterol, triglycerides, gamma-glutamyl transferase, AST and ALT, Uric acid, Na, K and Ca, microalbuminuria, high-sensitivity C-reactive protein, thyroid-stimulating hormone, thyroxine, insulin and Chagas disease serology HDL = High density lipoproteins; LDL = Low density lipoproteins; AST = Aspartate transaminase; ALT = Alanine transaminase. In a test and retest study with a mean interval of 29 days, which was conducted on 160 participants, higher scores were observed in all the retests, as well as a decrease in the average time taken to do the trail-making test version B. The memory tests presented moderate reliability, the verbal fluency tests presented good reliability and the trail-making test version B presented almost perfect reliability. 30 The verbal fluency tests require that interviewer should write down all the words said by the participant during a one-minute period. To avoid mistakes in the transcriptions, they were all recorded and checked. The supervisor of each center was also trained to calculate verbal fluency test scores, and a reliability study was designed to ascertain the degree of homogeneity of the interpretation among the ELSA centers. Intraclass correlation coefficients and Bland-Altman plots were used to examine patterns of rating disagreement among the verbal fluency test scores given by the supervisors at the six ELSA research centers, who independently judged 120 category tests (animals) and 120 phoneme tests (letter F). Their scores were compared with a reference standard score that was obtained through independent judgment by two experts. The scores were very similar among the ELSA centers, and a high level of agreement was observed between each center and the reference standard. 31 The data center for delineating and managing the data system was operated by a multidisciplinary team. A web-based system was developed, in order to enable online data entry, verification and editing while maintaining security and confidentiality, as well as in order to incorporate data that had been gathered on paper and obtained from reading centers. Processes for data extraction and cleaning were also developed in order to create databases in formats that would allow analyses in multiple statistical groups.
ELSA-Brasil was approved by the Research Ethics Committee of all the six participating centers and by the National Research Ethics
Committee. All the participants signed a free and informed consent statement before collection of any clinical and laboratory data. All international rules regarding data confidentiality during storage and analysis are being followed.
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RESULTS
The vast majority of the participants (15,101 out of 15,105) took the cognitive tests; 54% of them were women and 46% were men.
There were four cases of refusal to participate. The age range was from 35 to 74 years, with a median age of 51 years. With regard to working status, 80% were active public employees and 20% retired. Over 52% (7,498) had a university degree, 4204 (27.8%) had completed high school, 1898 (12.6%) had completed middle school, 1029 (6.8%) participants had studied in but not completed middle school and 22 (0.2%) were illiterate.
Significant differences in the distribution of sociodemographic characteristics according to investigation center were observed.
There was an overall predominance of women, with the highest contingents in the states of Bahia and Rio Grande do Sul. The mean age was 52.00 ± 9.08 years, with the youngest participants in the state of Rio de Janeiro, where the number of retired participants was also lower than in the other centers. Only 10% of the participants had attended school for less than five years, and the lowest percentages were found in Rio de Janeiro and Rio Grande do Sul ( Table 3) . given the figure memory test because of poor literacy skills.
In both tests, the participants' scores increased at the second and third attempts with means of 4 ± 1.6, 7.4 ± 1.6 and 8. The prospective analysis will enable us to compare intrapersonal performance, without the birth cohort effect, thus making it possible to measure the potential influence of risk factors, such as lifestyle, presence of diseases and use of medications. In addition to investigation of the natural evolution of cognition, the longitudinal study will allow us to investigate modifiable risk factors for cognitive decline, which is a public health priority, in an effort to prevent or delay occurrences of dementia.
Cognitive tests are used as a proxy for the participants' cognition. They present an advantage over clinical evaluation, in that they establish standardized scores, thus allowing comparison over time between people and studies. However, for this comparison, it has to be assumed that the cognitive tests have stable and reproducible results, which is not always true. The high consistency of verbal fluency test scores confirms that these tests are reliable and valid, and assures their use in multicenter studies.
As observed, reapplication of these tests, particularly when the interval between applications is short, may lead to an improvement in performance, due to the learning effect.
With the aim of minimizing this learning effect in the ELSA follow-up, in 2012, the ten CERAD words used in the memory test will be presented in a different order and the tests of verbal fluency will demand a different category (vegetables) and a different initial letter (A). The trail-making test version B, which presented high reproducibility when reapplied after short period, will be repeated. The baseline cognitive tests will be repeated exactly, in the second ELSA follow-up, after an interval of six years. This strategy will make it possible to investigate the influence of confounder factors on cognition, such as learning effects, on test performance.
Always bearing in mind the aphorism Brain function is too complex to be communicated in a single score, many other investigation strategies will be used during the development of the cohort, such as "nested case-control studies". Other tools for cognitive analysis will also be included, such as clinical-neurological evaluation and imaging tests. 32 Multifactorial analysis will be carried out, and the reliable change index will be calculated in order to determine any real and significant changes in cognitive test scores over time.
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CONCLUSION
Investigation of cognitive function decline in ELSA-Brasil takes into consideration its insidious onset, its long latency period and the need to identify factors that interact with the evolution of these processes. These approaches are only possible in longitudinal studies that include a large adult population. Such studies make it possible to identify the subclinical processes of dementia and are a source of knowledge for intervening in these risk factors, especially in modifiable ones.
